Penumbra Competitors
| PEN Stock | USD 339.10 0.84 0.25% |
Penumbra vs Baxter International Correlation
Poor diversification
The correlation between Penumbra and BAX is 0.71 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Penumbra and BAX in the same portfolio, assuming nothing else is changed.
Moving against Penumbra Stock
| 0.8 | AHC | Austco Healthcare | PairCorr |
| 0.79 | OTC | Ocumetics Technology Corp | PairCorr |
| 0.72 | IHC | Inspiration Healthcare | PairCorr |
| 0.7 | RHT | Resonance Health | PairCorr |
| 0.67 | NTI | Neurotech International | PairCorr |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Penumbra's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Penumbra Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Penumbra and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Penumbra and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Penumbra does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Penumbra Stock performing well and Penumbra Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Penumbra's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| GMED | 2.01 | 0.53 | 0.41 | 0.60 | 0.87 | 3.67 | 38.89 | |||
| BIO | 1.29 | (0.17) | 0.00 | (0.05) | 0.00 | 3.02 | 8.43 | |||
| ALGN | 1.67 | 0.47 | 0.34 | 0.41 | 1.09 | 4.70 | 11.36 | |||
| HQY | 1.66 | (0.35) | 0.00 | (0.29) | 0.00 | 2.57 | 16.72 | |||
| HIMS | 2.99 | (1.40) | 0.00 | (1.22) | 0.00 | 4.19 | 24.87 | |||
| DVA | 1.81 | 0.28 | 0.11 | 1.58 | 1.62 | 4.25 | 26.79 | |||
| CRL | 1.76 | (0.19) | 0.00 | (0.01) | 0.00 | 3.93 | 14.56 | |||
| HSIC | 1.18 | 0.16 | 0.10 | 0.30 | 1.26 | 2.63 | 6.00 | |||
| BAX | 1.55 | 0.24 | 0.13 | 0.35 | 1.48 | 3.50 | 9.48 |
Cross Equities Net Income Analysis
Compare Penumbra and related stocks such as Globus Medical, Bio Rad Laboratories, and Align Technology Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GMED | 48.7 M | 60.8 M | 73.8 M | 68.6 M | 92.5 M | 112.8 M | 104.3 M | 107.3 M | 156.5 M | 155.2 M | 102.3 M | 149.2 M | 190.2 M | 122.9 M | 103 M | 118.4 M | 117.1 M |
| BIO | 4.3 M | 178.2 M | 169.2 M | 77.8 M | 88.8 M | 113.1 M | 28.1 M | 114.7 M | 361 M | 1.8 B | 3.8 B | 4.3 B | (3.6 B) | (637.3 M) | (1.8 B) | (2.1 B) | (2 B) |
| ALGN | (15.4 M) | 66.7 M | 58.7 M | 64.3 M | 145.8 M | 144 M | 189.7 M | 231.4 M | 400.2 M | 442.8 M | 1.8 B | 772 M | 361.6 M | 445.1 M | 421.4 M | 410.4 M | 234 M |
| HQY | 11.2 M | 11.2 M | 11.2 M | 1.2 M | 10.2 M | 16.6 M | 26.4 M | 47.4 M | 73.9 M | 39.7 M | 8.8 M | (44.3 M) | (26.1 M) | 55.7 M | 96.7 M | 111.2 M | 116.8 M |
| HIMS | (75.2 M) | (75.2 M) | (75.2 M) | (75.2 M) | (75.2 M) | (75.2 M) | (75.2 M) | (75.2 M) | (75.2 M) | (72.1 M) | (18.1 M) | (107.7 M) | (65.7 M) | (23.5 M) | 126 M | 144.9 M | 152.2 M |
| DVA | 4.9 M | 478 M | 536 M | 633.4 M | 723.1 M | 269.7 M | 879.9 M | 663.6 M | 159.4 M | 811 M | 773.6 M | 978.5 M | 560.4 M | 691.5 M | 936.3 M | 746.8 M | 432.3 M |
| CRL | 23.4 M | 109.6 M | 97.3 M | 102.8 M | 126.7 M | 149.3 M | 154.8 M | 123.4 M | 226.4 M | 252 M | 364.3 M | 391 M | 486.2 M | 474.6 M | 10.3 M | 11.8 M | 11.2 M |
| HSIC | (10.9 M) | 367.7 M | 388.1 M | 444.1 M | 466.1 M | 479.1 M | 506.8 M | 406.3 M | 535.9 M | 508 M | 402.2 M | 623.9 M | 538 M | 416 M | 390 M | 448.5 M | 301.7 M |
| BAX | 137 M | 2.2 B | 2.3 B | 2 B | 2.5 B | 968 M | 5 B | 602 M | 1.5 B | 1 B | 1.1 B | 1.3 B | (2.4 B) | 2.7 B | (649 M) | (746.4 M) | (709 M) |
Penumbra and related stocks such as Globus Medical, Bio Rad Laboratories, and Align Technology Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Penumbra financial statement analysis. It represents the amount of money remaining after all of Penumbra operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Penumbra Competitive Analysis
The better you understand Penumbra competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Penumbra's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Penumbra's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Penumbra Competition Performance Charts
Five steps to successful analysis of Penumbra Competition
Penumbra's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Penumbra in relation to its competition. Penumbra's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Penumbra in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Penumbra's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Penumbra, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Penumbra position
In addition to having Penumbra in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Soft Drinks Thematic Idea Now
Soft Drinks
Entities manufacturing and distributing non alcoholic beverages across different markets. The Soft Drinks theme has 12 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Soft Drinks Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Penumbra Correlation with its peers. To learn how to invest in Penumbra Stock, please use our How to Invest in Penumbra guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Will Health Care Equipment & Supplies sector continue expanding? Could Penumbra diversify its offerings? Factors like these will boost the valuation of Penumbra. Anticipated expansion of Penumbra directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Penumbra data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.56 | Earnings Share 4.2 | Revenue Per Share | Quarterly Revenue Growth 0.178 | Return On Assets |
Investors evaluate Penumbra using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Penumbra's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Penumbra's market price to deviate significantly from intrinsic value.
It's important to distinguish between Penumbra's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Penumbra should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Penumbra's market price signifies the transaction level at which participants voluntarily complete trades.